다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Investigative and clinical urology, v.64 no.1, 2023년, pp.20 - 30
Shin, Dongho (Department of Urology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea .) , Zhu, Guan Qun (Catholic Integrative Medicine Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Korea .) , Tian, Wen Jie (Catholic Integrative Medicine Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Korea .) , Ahn, Sun Tae (Department of Urology, Korea University College of Medicine, Seoul, Korea .) , Jeon, Seung Hwan (Catholic Integrative Medicine Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Korea .) , Cho, Hyuk Jin (Department of Urology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea .) , Ha, U-Syn (Department of Urology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea .) , Hong, Sung-Hoo (De) , Lee, Ji Youl , Kim, Sae Woong , Moon, Du Geon , Bae, Woong Jin
AI-Helper
PurposeTo evaluate the efficacy and safety of Quisqualis indica in men with moderate lower urinary tract symptoms (LUTS).Materials and MethodsA total of 135 subjects with International Prostate Symptom Score (IPSS) of 8–19 were randomized in 2 centers from June 2018 to April 2019. Patients we...
1 Launer BM McVary KT Ricke WA Lloyd GL The rising worldwide impact of benign prostatic hyperplasia BJU Int 2021 127 722 728 33124118
2 Lee YJ Lee JW Park J Seo SI Chung JI Yoo TK Nationwide incidence and treatment pattern of benign prostatic hyperplasia in Korea Investig Clin Urol 2016 57 424 430
3 McVary KT Roehrborn CG Avins AL Barry MJ Bruskewitz RC Donnell RF Update on AUA guideline on the management of benign prostatic hyperplasia J Urol 2011 185 1793 1803 21420124
4 Lee A Lee HJ Foo KT Can men with prostates sized 80 mL or larger be managed conservatively? Investig Clin Urol 2017 58 359 364
5 Marberger M Chartier-Kastler E Egerdie B Lee KS Grosse J Bugarin D A randomized double-blind placebo-controlled phase 2 dose-ranging study of onabotulinumtoxinA in men with benign prostatic hyperplasia Eur Urol 2013 63 496 503 23098762
6 Zlotta AR Teillac P Raynaud JP Schulman CC Evaluation of male sexual function in patients with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH) treated with a phytotherapeutic agent (Permixon ® ), tamsulosin or finasteride Eur Urol 2005 48 269 276 15939527
7 Cai T Verze P La Rocca R Palmieri A Tiscione D Luciani LG The clinical efficacy of pollen extract and vitamins on chronic prostatitis/chronic pelvic pain syndrome is linked to a decrease in the pro-inflammatory cytokine interleukin-8 World J Mens Health 2017 35 120 128 28497911
8 Ledda A Belcaro G Cesarone MR Dugall M Schönlau F Investigation of a complex plant extract for mild to moderate erectile dysfunction in a randomized, double-blind, placebo-controlled, parallel-arm study BJU Int 2010 106 1030 1033 20184576
9 Park HJ Kim HW Choe S Kim CH Park NC The use of phytotherapy in male patients with a lower urinary tract symptoms due to benign prostatic hyperplasia: single center study Korean J Androl 2011 29 76 84
10 Madersbacher S Marszalek M Lackner J Berger P Schatzl G The long-term outcome of medical therapy for BPH Eur Urol 2007 51 1522 1533 17416456
11 Mukhopadhyay R Kazi J Debnath MC Synthesis and characterization of copper nanoparticles stabilized with Quisqualis indica extract: evaluation of its cytotoxicity and apoptosis in B16F10 melanoma cells Biomed Pharmacother 2018 97 1373 1385 29156527
12 Rout PK Kumar P Rao YR Kumar A Bawankule DU Singh R A quinoline alkaloid rich Quisqualis indica floral extract enhances the bioactivity Nat Prod Res 2021 35 1632 1638 31264476
13 Kim DG Kwon HJ Lim JH Kim JH Lee KP Quisqualis indica extract ameliorates low urinary tract symptoms in testosterone propionate-induced benign prostatic hyperplasia rats Lab Anim Res 2020 36 26 32793460
14 Ub Wijerathne C Park HS Jeong HY Song JW Moon OS Seo YW Quisqualis indica improves benign prostatic hyper plasia by regulating prostate cell proliferation and apoptosis Biol Pharm Bull 2017 40 2125 2133 28943529
15 Nair AB Jacob S A simple practice guide for dose conversion between animals and human J Basic Clin Pharm 2016 7 27 31 27057123
16 Chung JH Oh CY Kim JH Ha US Kim TH Lee SH Efficacy and safety of tamsulosin 0.4 mg single pills for treatment of Asian patients with symptomatic benign prostatic hyperplasia with lower urinary tract symptoms: a randomized, double-blind, phase 3 trial Curr Med Res Opin 2018 34 1793 1801 29490509
17 Holder KG Galvan B Knight AS Ha F Collins R Weaver PE Possible clinical implications of prostate capsule thickness and glandular epithelial cell density in benign prostate hyperplasia Investig Clin Urol 2021 62 423 429
18 Gratzke C Barber N Speakman MJ Berges R Wetterauer U Greene D Prostatic urethral lift vs transurethral resection of the prostate: 2-year results of the BPH6 prospective, multicentre, randomized study BJU Int 2017 119 767 775 27862831
19 Alonso-Magdalena P Brössner C Reiner A Cheng G Sugiyama N Warner M A role for epithelial-mesenchymal transition in the etiology of benign prostatic hyperplasia Proc Natl Acad Sci U S A 2009 106 2859 2863 19196965
20 Song JH Hwang B Chung HJ Moon B Kim JW Ko K Peanut sprout extracts cultivated with fermented sawdust medium inhibits benign prostatic hyperplasia in vitro and in vivo World J Mens Health 2020 38 385 396 32202087
21 Trivisonno LF Sgarbossa N Alvez GA Fieiras C Escobar Liquitay CM Jung JH Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement: a systematic review and meta-analysis Investig Clin Urol 2021 62 520 534
22 Carson C 3rd Rittmaster R The role of dihydrotestosterone in benign prostatic hyperplasia Urology 2003 61 4 Suppl 1 2 7
23 Alcaraz A Hammerer P Tubaro A Schröder FH Castro R Is there evidence of a relationship between benign prostatic hyperplasia and prostate cancer? Findings of a literature review Eur Urol 2009 55 864 875 19027219
24 Park HJ Won JE Sorsaburu S Rivera PD Lee SW Urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) and LUTS/BPH with erectile dysfunction in Asian men: a systematic review focusing on tadalafil World J Mens Health 2013 31 193 207 24459652
25 Baek JM Kim HJ Nam MW Park HJ Yeon SH Oh MH Standardized seed extract of Quisqualis indica (HU-033) attenuates testosterone propionate-induced benign prostatic hyperplasia via α1-adrenergic receptors and androgen/estrogen signaling Prev Nutr Food Sci 2019 24 492 497 31915646
26 Gacci M Andersson KE Chapple C Maggi M Mirone V Oelke M Latest evidence on the use of phosphodiesterase type 5 inhibitors for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia Eur Urol 2016 70 124 133 26806655
27 Lee SW Son H Lee SW Cho KS Moon DG Yang DY Efficacy and safety of mirodenafil oro-dispersible film in Korean patients with erectile dysfunction: a double-blind, randomized, placebo-controlled, parallel-group, multicenter, phase IV study World J Mens Health 2022 40 280 289 33987996
28 Oelke M Shinghal R Sontag A Baygani SK Donatucci CF Time to onset of clinically meaningful improvement with tadalafil 5 mg once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: analysis of data pooled from 4 pivotal, double-blind, placebo controlled studies J Urol 2015 193 1581 1589 25437533
29 Brock GB McVary KT Roehrborn CG Watts S Ni X Viktrup L Direct effects of tadalafil on lower urinary tract symptoms versus indirect effects mediated through erectile dysfunction symptom improvement: integrated data analyses from 4 placebo controlled clinical studies J Urol 2014 191 405 411 24096120
30 Park NC Kim SW Hwang SY Park HJ Efficacy and safety of an herbal formula (KBMSI-2) in the treatment of erectile dysfunction: a preliminary clinical study Investig Clin Urol 2019 60 275 284
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.